tradingkey.logo
搜尋

Standard BioTools Inc

LAB
添加自選
0.913USD
+0.046+5.32%
收盤 07/02, 13:00美東報價延遲15分鐘
356.16M總市值
4.57本益比TTM

Standard BioTools Inc

0.913
+0.046+5.32%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+5.32%

5天

+24.34%

1月

-28.12%

6月

-28.12%

今年開始到現在

-28.68%

1年

-32.38%

關鍵數據
0.850今開
0.929最高
4.45M成交量
4.57本益比TTM
虧損本益比動
--股利TTM
1.14%換手率
0.867昨收
0.850最低
3.32M成交額
虧損本益比靜
0.63市淨率
0.00%股息率 TTM
-8.22%ROA
1.72052週最高
0.67量比
-184.90M淨利潤
390.14M總股本
0.1999每股盈餘TTM
1.37Beta
-9.86%ROE
0.87052週最低
9.14%振幅
53.48%毛利率
356.16M總市值
-7.78回報/風險
4.08%風險率

TradingKey Standard BioTools Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Standard BioTools Inc當前公司基本面數據相對非常健康,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名86/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為1.55。中期看,股價處於平穩狀態。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Standard BioTools Inc評分

相關信息

行業排名
86 / 204
全市場排名
199 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Standard BioTools Inc亮點

亮點風險
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
業績增長期
公司處於發展階段,最新年度總收入85.33M美元
估值高估
公司最新PE估值4.57,處於3年歷史高位
機構加倉
最新機構持股317.36M股,環比增加0.24%
活躍度增加
近期活躍度增加,過去20天平均換手率1.91

分析師目標

基於 2 分析師
買入
評級
1.550
目標均價
+78.82%
漲幅空間

Standard BioTools Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Standard BioTools Inc簡介

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
公司代碼LAB
公司Standard BioTools Inc
CEOEgholm (Michael)
網址https://www.standardbio.com/

常見問題

Standard BioTools Inc(LAB)的當前股價是多少?

Standard BioTools Inc(LAB)的當前股價是 0.91。

Standard BioTools Inc 的股票代碼是什麼?

Standard BioTools Inc的股票代碼是LAB。

Standard BioTools Inc股票的52週最高點是多少?

Standard BioTools Inc股票的52週最高點是1.72。

Standard BioTools Inc股票的52週最低點是多少?

Standard BioTools Inc股票的52週最低點是0.87。

Standard BioTools Inc的市值是多少?

Standard BioTools Inc的市值是356.16M。

現在Standard BioTools Inc(LAB)的股票是買入、持有還是賣出?

根據分析師評級,Standard BioTools Inc(LAB)的總體評級為買入,目標價格為1.55。

Standard BioTools Inc(LAB)股票的每股收益(EPS TTM)是多少

Standard BioTools Inc(LAB)股票的每股收益(EPS TTM)是-0.20。